These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18453543)

  • 1. Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivo.
    Yu W; Sun X; Clough N; Cobos E; Tao Y; Dai Z
    Carcinogenesis; 2008 Sep; 29(9):1717-24. PubMed ID: 18453543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/CAS9-mediated knockout of Abi1 inhibits p185
    Faulkner J; Jiang P; Farris D; Walker R; Dai Z
    J Hematol Oncol; 2020 Apr; 13(1):34. PubMed ID: 32276588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcr-Abl induces abnormal cytoskeleton remodeling, beta1 integrin clustering and increased cell adhesion to fibronectin through the Abl interactor 1 pathway.
    Li Y; Clough N; Sun X; Yu W; Abbott BL; Hogan CJ; Dai Z
    J Cell Sci; 2007 Apr; 120(Pt 8):1436-46. PubMed ID: 17389688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK1-mediated phosphorylation of Abi1 attenuates Bcr-Abl-induced F-actin assembly and tyrosine phosphorylation of WAVE complex during mitosis.
    Zhuang C; Tang H; Dissanaike S; Cobos E; Tao Y; Dai Z
    J Biol Chem; 2011 Nov; 286(44):38614-38626. PubMed ID: 21900237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression or knock-down of runt-related transcription factor 1 affects BCR-ABL-induced proliferation and migration in vitro and leukemogenesis in vivo in mice.
    Yang LJ; Yu WD; DU JB; Chao S; Chen MX; Zhao HH; Guo JZ
    Chin Med J (Engl); 2009 Feb; 122(3):331-7. PubMed ID: 19236814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role for Gab2 in transformation by BCR/ABL.
    Sattler M; Mohi MG; Pride YB; Quinnan LR; Malouf NA; Podar K; Gesbert F; Iwasaki H; Li S; Van Etten RA; Gu H; Griffin JD; Neel BG
    Cancer Cell; 2002 Jun; 1(5):479-92. PubMed ID: 12124177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abl interactor 1 regulates Src-Id1-matrix metalloproteinase 9 axis and is required for invadopodia formation, extracellular matrix degradation and tumor growth of human breast cancer cells.
    Sun X; Li C; Zhuang C; Gilmore WC; Cobos E; Tao Y; Dai Z
    Carcinogenesis; 2009 Dec; 30(12):2109-16. PubMed ID: 19843640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the adapter protein Abi1 in actin-associated signaling and smooth muscle contraction.
    Wang T; Cleary RA; Wang R; Tang DD
    J Biol Chem; 2013 Jul; 288(28):20713-22. PubMed ID: 23740246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the Src homology 3 domain and C-terminal proline-rich sequences in Bcr-Abl prevents Abl interactor 2 degradation and spontaneous cell migration and impairs leukemogenesis.
    Dai Z; Kerzic P; Schroeder WG; McNiece IK
    J Biol Chem; 2001 Aug; 276(31):28954-60. PubMed ID: 11387320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abl-1-bridged tyrosine phosphorylation of VASP by Abelson kinase impairs association of VASP to focal adhesions and regulates leukaemic cell adhesion.
    Maruoka M; Sato M; Yuan Y; Ichiba M; Fujii R; Ogawa T; Ishida-Kitagawa N; Takeya T; Watanabe N
    Biochem J; 2012 Feb; 441(3):889-99. PubMed ID: 22014333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Abl/Abi signaling links WAVE regulatory complex to Cbl E3 ubiquitin ligase and is essential for breast cancer cell metastasis.
    Jiang P; Tang S; Hudgins H; Smalligan T; Zhou X; Kamat A; Dharmarpandi J; Naguib T; Liu X; Dai Z
    Neoplasia; 2022 Oct; 32():100819. PubMed ID: 35839699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.
    Adam M; Pogacic V; Bendit M; Chappuis R; Nawijn MC; Duyster J; Fox CJ; Thompson CB; Cools J; Schwaller J
    Cancer Res; 2006 Apr; 66(7):3828-35. PubMed ID: 16585210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-protein coupled receptor 34 activates Erk and phosphatidylinositol 3-kinase/Akt pathways and functions as alternative pathway to mediate p185Bcr-Abl-induced transformation and leukemogenesis.
    Zuo B; Li M; Liu Y; Li K; Ma S; Cui M; Qin Y; Zhu H; Pan X; Guo J; Dai Z; Yu W
    Leuk Lymphoma; 2015 Jul; 56(7):2170-81. PubMed ID: 25363403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of sialidase Neu2 in leukemic K562 cells induces apoptosis by impairing Bcr-Abl/Src kinases signaling.
    Tringali C; Lupo B; Anastasia L; Papini N; Monti E; Bresciani R; Tettamanti G; Venerando B
    J Biol Chem; 2007 May; 282(19):14364-72. PubMed ID: 17374613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR/ABL activates mdm2 mRNA translation via the La antigen.
    Trotta R; Vignudelli T; Candini O; Intine RV; Pecorari L; Guerzoni C; Santilli G; Byrom MW; Goldoni S; Ford LP; Caligiuri MA; Maraia RJ; Perrotti D; Calabretta B
    Cancer Cell; 2003 Feb; 3(2):145-60. PubMed ID: 12620409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signaling.
    Rubbi L; Titz B; Brown L; Galvan E; Komisopoulou E; Chen SS; Low T; Tahmasian M; Skaggs B; Müschen M; Pellegrini M; Graeber TG
    Sci Signal; 2011 Mar; 4(166):ra18. PubMed ID: 21447799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MT1-MMP as a downstream target of BCR-ABL/ABL interactor 1 signaling: polarized distribution and involvement in BCR-ABL-stimulated leukemic cell migration.
    Sun X; Li Y; Yu W; Wang B; Tao Y; Dai Z
    Leukemia; 2008 May; 22(5):1053-6. PubMed ID: 17943163
    [No Abstract]   [Full Text] [Related]  

  • 18. The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing.
    Skorski T; Nieborowska-Skorska M; Wlodarski P; Wasik M; Trotta R; Kanakaraj P; Salomoni P; Antonyak M; Martinez R; Majewski M; Wong A; Perussia B; Calabretta B
    Blood; 1998 Jan; 91(2):406-18. PubMed ID: 9427693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abl-interactor-1 (Abi1) has a role in cardiovascular and placental development and is a binding partner of the alpha4 integrin.
    Ring C; Ginsberg MH; Haling J; Pendergast AM
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):149-54. PubMed ID: 21173240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAK silencing inhibits leukemogenesis in BCR/ABL-transformed hematopoietic cells.
    Le Y; Xu L; Lu J; Fang J; Nardi V; Chai L; Silberstein LE
    Am J Hematol; 2009 May; 84(5):273-8. PubMed ID: 19358301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.